Benefits
Synergistic NAD+ elevation beyond NR alone
The NR + D-ribose combination produces greater NAD+ elevation than equivalent doses of NR alone — because D-ribose provides the ribose backbone required for the final adenylation step of NAD+ synthesis (NMN → NAD+), relieving a rate-limiting step that constrains NR's conversion efficiency when ribose supply is limiting.
Simultaneous ATP and NAD+ restoration
RiaGev® uniquely addresses both major cellular energy currencies: NAD+ (for metabolic signaling, sirtuin activation, and DNA repair) and ATP (for direct cellular work, muscle contraction, and biosynthesis). Most NAD+ supplements address only NAD+; RiaGev® is formulated to restore both pools simultaneously — particularly relevant in conditions of combined energy depletion.
Mitochondrial bioenergetics optimization
With both NAD+ and ATP pools restored, mitochondrial function can operate at full capacity: NAD+ supports electron transport chain efficiency and sirtuin-mediated mitochondrial quality control, while ATP provides the direct energy currency for cellular processes. The combination produces comprehensive mitochondrial bioenergetic support.
Cellular aging and longevity support
NAD+ depletion is a primary driver of cellular aging — reducing sirtuin activity, impairing DNA repair, and compromising mitochondrial function. RiaGev® addresses this age-related NAD+ decline while simultaneously supporting ATP production, providing a comprehensive cellular energy restoration approach for healthy aging.
Mechanism of action
Complementary NAD+ biosynthesis pathway engagement
NR enters the NAD+ salvage pathway via NR kinase (NRK1/2), producing NMN which requires NMNAT enzymes to add an AMP group (from ATP) to form NAD+. D-ribose provides the ribose backbone for ATP synthesis via the pentose phosphate pathway, ensuring the AMP substrate for NMNAT is available — relieving a potential rate-limiting constraint when intracellular ribose is limiting.
Dual energy pool restoration
NR preferentially elevates the NAD+ pool (via the NR salvage pathway), while D-ribose preferentially restores the adenine nucleotide pool (ATP, ADP, AMP) via de novo purine synthesis. The combination provides substrate for both pools simultaneously, producing a more comprehensive cellular energy restoration than either alone.
Sirtuin and PARP-1 co-activation support
With elevated NAD+, both sirtuins (SIRT1–7 deacylases governing longevity pathways) and PARP-1 (DNA repair) have adequate substrate. With replenished ATP, the cellular machinery downstream of sirtuin signaling (mitochondrial biogenesis, DNA repair synthesis, protein quality control) has the energy currency to actually execute these processes — completing the energy restoration loop.
Clinical trials
Randomized, crossover pharmacokinetic study comparing RiaGev® (NR + D-ribose complex) vs equivalent doses of NR alone and D-ribose alone on whole-blood NAD+. Note: full peer-reviewed publication for RiaGev®-specific PK trial may be limited; primary documentation through Bioenergy Life Science.
Per manufacturer.
RiaGev® produced greater whole-blood NAD+ elevation than equivalent NR dose alone. Critical caveat: as primarily manufacturer-published data, claims warrant independent peer-reviewed validation. The 'synergistic' framing relies on dose-equivalent comparisons that should be scrutinized.
Pilot study examining NR + D-ribose combination effects on energy levels, cognitive function, and fatigue markers in adults with fatigue complaints. (Bioenergy Life Science)
50 healthy middle-aged adults (ages 36–65). Randomized, triple-blind, placebo-controlled crossover; 1520 mg RiaGev® twice daily for 7 days vs placebo, 7-day washout between arms. Blood samples on days 1, 3, 5, and 8.
NAD+ metabolome significantly increased; NADP+ rose 27% vs placebo (p=0.033). Glutathione and high-energy phosphates also increased. Blood glucose significantly reduced (p=0.013) without changes in insulin secretion, suggesting improved insulin sensitivity. Salivary cortisol decreased (p=0.026). Subjects reported less fatigue, improved mental concentration, and improved motivation (CIS questionnaire). No adverse events. Established RiaGev® as safe and efficacious NAD+ enhancer in middle-aged adults.